Georg Sprenger

Prof. Dr. Georg Sprenger

Institute of Microbiology, University of Stuttgart, Stuttgart, Germany
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

11 July 2014 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
KGKatrin Gottlieb
Katrin Gottlieb
CAChristoph Albermann
Christoph Albermann
Georg SprengerGeorg Sprenger
Georg Sprenger
For the production of L-phenylalanine (L-Phe), two molecules of phosphoenolpyruvate (PEP) and one molecule erythrose-4-phosphate (E4P) are necessary. PEP stems from glycolysis whereas E4P is formed in the pentose phosphate pathway (PPP). Glucose, commonly used for L-Phe production with recombinant E. coli, is taken up via the PEP-dependent phosphotransferase system which delivers glucose-6-phosphate (G6P). G6P enters either glycolysis or the PPP. In contrast, glycerol is phosphorylated by an ATP-dependent glycerol kinase (GlpK) thus saving one PEP. However, two gluconeogenic reactions (fructose-1,6-bisphosphate aldolase, fructose-1,6-bisphosphatase, FBPase) are necessary for growth and provision of E4P. Glycerol has become an important carbon source for biotechnology and reports on production of L-Phe from glycerol are available. However, the influence of FBPase and transketolase reactions on L-Phe production has not been reported.

3 April 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
IKIskander Khusainov
Iskander Khusainov
BFBulat Fatkhullin
Bulat Fatkhullin
SPSimone Pellegrino
Simone Pellegrino
ABAydar Bikmullin
Aydar Bikmullin
WLWen-Ti Liu
Wen-Ti Liu
MYMarat Yusupov
Marat Yusupov
For the sake of energy preservation, bacteria, upon transition to stationary phase, tone down their protein synthesis. This process is favored by the reversible binding of small stress-induced proteins to the ribosome to prevent unnecessary translation. One example is the conserved bacterial ribosome silencing factor (RsfS) that binds to uL14 protein onto the large ribosomal subunit and prevents its association with the small subunit. Here we describe the binding mode of Staphylococcus aureus RsfS to the large ribosomal subunit and present a 3.2 Å resolution cryo-EM reconstruction of the 50S-RsfS complex together with the crystal structure of uL14-RsfS complex solved at 2.3 Å resolution. The understanding of the detailed landscape of RsfS-uL14 interactions within the ribosome shed light on the mechanism of ribosome shutdown in the human pathogen S. aureus and might deliver a novel target for pharmacological drug development and treatment of bacterial infections.

8 December 2006
Verified
Book Chapter
Closed access
PDF file
Georg SprengerGeorg Sprenger
Georg Sprenger

31 October 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
NPNavaneethan Palanisamy
Navaneethan Palanisamy
ADAnna Degen
Anna Degen
AMAnna Morath
Anna Morath
JBJara Ballestin Ballestin
Jara Ballestin Ballestin
CJClaudia Juraske
Claudia Juraske
BVBarbara Di Ventura
Barbara Di Ventura
To build or dissect complex pathways in bacteria and mammalian cells, it is often necessary to recur to at least two plasmids, for instance harboring orthogonal inducible promoters. Here we present SiMPl, a method based on rationally designed split enzymes and intein-mediated protein trans-splicing, allowing the selection of cells carrying two plasmids with a single antibiotic. We show that, compared to the traditional method based on two antibiotics, SiMPl increases the production of the antimicrobial non-ribosomal peptide indigoidine and the non-proteinogenic aromatic amino acid para-amino-L-phenylalanine from bacteria. Using a human T cell line, we employ SiMPl to obtain a highly pure population of cells double positive for the two chains of the T cell receptor, TCRα and TCRβ, using a single antibiotic. SiMPl has profound implications for metabolic engineering and for constructing complex synthetic circuits in bacteria and mammalian cells.

1 January 2020 in Journal of Biotechnology
Verified
Journal Article
Closed access
JTJulia Tröndle
Julia Tröndle
KSKristin Schoppel
Kristin Schoppel
ABArne Bleidt
Arne Bleidt
NTNatalia Trachtmann
Natalia Trachtmann
Georg SprengerGeorg Sprenger
Georg Sprenger
DWDirk Weuster-Botz
Dirk Weuster-Botz